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Abstract  
Aims/Hypothesis 
Evidence of the role of cytomegalovirus (CMV) infection in the pathogenesis of type 1 diabetes 
(T1D) has remained inconclusive. Our aim was to elucidate the possible role of CMV infection in 
the initiation of islet autoimmunity and in the progression to clinical T1D among children with 
HLA-conferred T1D risk.  
Methods  
A total of 1402 children from the prospective Type 1 Diabetes Prediction and Prevention (DIPP) 
study were analyzed for CMV-specific IgG antibodies during early childhood. All children carried 
HLA-DQ genotypes associated with increased risk for T1D. The effect of CMV infection on the 
appearance of T1D-associated autoantibodies (IAA, GADA and IA-2A, n=356) and on the 
progression rate to clinical T1D (n=233) were analyzed with Kaplan-Meier survival analysis and log-
rank test. 
Results 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
Early childhood CMV infection was inversely associated with the development of T1D during 
childhood. Cumulative progression to T1D was decreased in subjects with an early CMV infection 
(p=0.035). In further analyses, the effect of early CMV infection on the initiation of islet 
autoimmunity and progression to clinical T1D were examined separately. Interestingly, early CMV 
infection did not affect the appearance of T1D-associated autoantibodies but a decelerating effect 
was observed on the progression rate from islet autoimmunity to clinical T1D (p=0.015). 
Conclusion 
Our results suggest that an early childhood CMV infection may decelerate the progression from 
islet autoimmunity to clinical T1D among at-risk children and may thus protect these children from 
progressing to T1D during childhood.  
Keywords: cytomegalovirus, CMV, type 1 diabetes, autoantibodies, 
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Introduction  
Type 1 diabetes (T1D) is considered to arise from complex gene-environmental interactions that 
affect the immune system. From the heterogeneous group of environmental factors implicated, 
viruses have been a major target of interest. Several viruses, including enteroviruses and 
cytomegalovirus (CMV) have been suggested to affect the pathogenesis of T1D. However, the 
results of previous studies concerning the role of most viruses, including CMV, have been largely 
controversial [1].  
CMV is a common herpes group virus that causes a lifelong latent infection. CMV seroprevalence 
in adults varies geographically from 40 % to 100 % [2]. In Finland, similar to other Western 
countries, approximately 50 % of pregnant women are seropositive for CMV-specific IgG 
antibodies [3]. More than 75 % of childhood CMV infections are acquired in early childhood, 
transmitted typically perinatally or during the first year of life through saliva, maternal genital 
secretions or breast milk after reactivation of the latent virus in the mother. Thereafter, the 
incidence rate of CMV infection, stays rather stable until it peaks again at the age of 4 to 5 years.  
[4].  
We have earlier analyzed the association of perinatal CMV infection and the appearance of early 
signs of islet autoimmunity and clinical T1D in a prospective cohort of children with HLA-conferred 
susceptibility to T1D [5]. In that analysis, no association of perinatal CMV infection with islet 
autoimmunity was observed. In contrast, a trend for a protective effect of perinatal CMV infection 
on the development of clinical T1D was seen, but the result was statistically non-significant. In the 
current study, we aimed to further clarify the role of perinatal CMV infection in the pathogenesis 
of T1D by analyzing samples from a larger cohort of children with HLA-associated T1D risk.  
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Methods  
Study cohort  
The study subjects participated in the prospective Finnish Type 1 Diabetes Prediction and 
Prevention (DIPP) study. In the DIPP study, children born at three university hospitals (Turku, 
Tampere and Oulu) are first screened for HLA-DR/DQ associated susceptibility to T1D [6]. Children 
carrying selected HLA genotypes associated with increased T1D risk are recruited to a follow-up 
program that includes regular blood sampling for measurement of islet autoantibodies. In Turku, 
samples are collected at 3-month intervals until the age of 24 months, and thereafter at 6-month 
intervals. In Oulu and Tampere, samples are collected at the ages of 3, 6, 12, 18 and 24 months, 
and thereafter at yearly intervals. Before 2003, the appearance of classical islet cell autoantibodies 
(ICA) was tested using an immunofluorescence method, and if positive, insulin autoantibodies 
(IAA), antibodies to the 65 kD isoform of glutamic acid decarboxylase (GADA) and antibodies to 
the insulinoma antigen-2 (IA-2A) were subsequently tested from all samples of these subjects [7]. 
Since 2003, these three biochemical autoantibodies have been tested from all samples. After the 
appearance of autoantibodies, the sample collection frequency is raised to every three months in 
all of the study centers. 
The study cohort comprised 356 children who tested persistently positive, i.e. in two consecutive 
positive samples taken 3 months apart, for at least one of the biochemical islet autoantibodies 
(IAA, GADA, IA-2A). 1046 autoantibody-negative control subjects matched for age, gender and 
clinical center were used as controls. Among the autoantibody-positive subjects, 233 children 
developed clinical T1D during the follow-up. All subjects were analyzed for CMV-specific IgG-
antibodies from serum samples obtained between the age of 9 and 24 months. Sampling was 
conducted independently from the case status with the serum samples available. The length of the 
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prospective follow-up for the appearance of islet autoantibodies ranged from 0.9 to 16.0 years 
(median 11.9 years) measured from birth to the age of seroconversion or the age at the end of the 
follow-up. For clinical T1D, the length of follow-up ranged from 0.8 to 16.0 years (median 14.8 
years) measured from birth to the age of diagnosis or the age at the end of the follow-up. The 
children were followed until the age of 16 years.  
Diabetes was diagnosed according to the WHO criteria. The study protocol was approved by the 
local ethics committees and a written informed consent was obtained from all parents of the 
children participating in the study. 
Study design 
The effect of perinatal CMV infection on the development of clinical T1D, and separately, on the 
appearance of islet autoantibodies, and on the progression rate from the initiation of islet 
autoimmunity, i.e. appearance of islet autoantibodies, to clinical T1D was analyzed.  
Cytomegalovirus IgG-antibody measurement 
CMV-specific IgG antibodies were determined from serum samples using an in-house enzyme 
immune assay described in detail earlier [8]. The cut-off value for positivity was set to ≥0.15 OD. 
To improve accuracy, samples with absorbance readings slightly below the reliable cut-off value 
(0.11-0.149 OD) were excluded (n=41) from the final statistical analyses.  
Statistical analysis 
Statistical analyses were performed with SPSS statistics 23. Kaplan-Meier survival analysis with Log 
Rank test was applied to compare the effect of early CMV infection on the development of T1D, on 
the appearance of islet autoantibodies, and on the progression rate from the initiation of islet 
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autoimmunity to clinical T1D. Chi-square test was used to compare the frequencies of clinical T1D 
in children positive or negative for CMV-specific IgG antibodies. 
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Results 
The prevalence of an early CMV infection was determined by measuring CMV-specific IgG 
antibodies before the age of 2 years in 1361 (97.1%) of the 1402 children studied from the DIPP 
follow-up cohort and these were included in the statistical analyses. From these children, 321 
(23.6%) tested positive for CMV antibodies indicating an early, most probably perinatal, CMV 
infection (Tables 1). 
Progression of children with an early CMV infection to clinical T1D during the follow-up was 
significantly decreased compared to the children without an early CMV infection (p=0.035, Kaplan-
Meier survival analysis, log-rank test) (Figure 1).  The number of children developing T1D in the 
group with an early CMV infection was 42/321 (13.1%) compared to 186/1040 (17.9%) in those 
without CMV infection (P=0.044, Chi-square test). 
To further investigate the role of early CMV infection in the pathogenesis of T1D, we analyzed 
separately the effect of CMV infection on the initiation of islet autoimmunity characterized by the 
appearance of islet autoantibodies, and on the progression rate of established islet autoimmunity 
to clinical T1D (Table 2.). No significant effect of early CMV infection was observed on the 
appearance of islet autoantibodies (p=0.357, Kaplan-Meier survival analysis). Among the group of 
321 children with an early CMV infection, 76 (23.7%) developed humoral signs of beta-cell 
autoimmunity compared to 269 (25.9%) among the 1040 children without CMV infection in 
infancy (Figure 2).  
As there was no effect between early childhood CMV infection and the development of islet 
autoantibodies, we set out to explore whether the decreased progression to clinical T1D would be 
attributable to a reduced rate of progression from the initiation of autoimmunity to clinical T1D. 
Indeed, we observed that the progression rate was decelerated among autoantibody-positive 
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children with an early CMV infection compared to children without CMV infection during infancy 
(p=0.015, Kaplan-Meier survival analysis) (Figure 3). During the follow-up, 41 (53.9%) 
autoantibody-positive children with early CMV infection progressed to clinical T1D compared to 
181 (67.3%) autoantibody-positive children without CMV infection during infancy (P=0.032, Chi 
square test).  
In further analyses, no significant effect of early CMV infection on the appearance of a second or 
third autoantibody was detected: n=59 (18.4%) vs n=221 (21.3%) for the appearance of a second 
autoantibody (p=0.207, Kaplan-Meier survival analysis) and n=34 (10.6%) vs n=138 (13.3%), for the 
appearance of third autoantibody (p=0.107), in CMV-seropositive and –seronegative groups, 
respectively. We neither observed any difference between the groups in the progression rate to 
clinical T1D from the appearance of the second or third persistent islet autoantibody: n=38 
(64.4%) vs n=162 (73.3%) for progression to T1D after the appearance of the second islet 
autoantibody (p=0.224) and n=25 (73.5%) vs n=110 (79.7%) for progression to T1D after the 
appearance of the third islet autoantibody (p=0.222) in CMV-seropositive and –seronegative 
groups, respectively. 
We also tested whether CMV infection had an effect on the appearance of the islet autoantibodies 
(IAA, GADA or IA-2A) separately. Early CMV infection did not affect the appearance of GADA or IA-
2A (p=0.652 and 0.224, respectively). However, a tendency for a protective effect on the 
appearance of IAA was observed (p=0.072).   
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Discussion 
Several virus infections have been implicated in the pathogenesis of T1D. Accumulating data 
support an association between enterovirus infections and T1D, but the role of other virus 
infections has remained unclear. Currently, there is no definite evidence for a role of CMV 
infection in the pathogenesis of T1D. [1].  
In Western countries CMV infection is typically acquired during the perinatal period and infancy 
but less commonly during later childhood [4]. Early childhood is also a critical time period for the 
pathogenesis of T1D as most children who eventually develop the disease in childhood 
seroconvert to positivity for islet autoantibodies during the first three years of life [11, 12]. 
We have earlier analyzed the possible effect of early, mostly perinatal CMV infection on 
development of T1D in a smaller cohort of children with increased genetic risk for the disease [5]. 
That study did not suggest an increased risk associated with early CMV infection but instead 
demonstrated a trend for a decreased risk of T1D among subjects with CMV infection. In the 
current study, we aimed to further assess the possible effect of early-life CMV infection by 
analyzing an extended cohort of children participating in the DIPP study. Here, we observed a 
statistically significant protective effect of an early CMV infection for the development of T1D that 
was due to a decelerated progression rate to T1D in subjects who had already established islet 
autoimmunity. Our observations suggest that early-life CMV infection delays further progression 
of an already established autoimmune process but does not directly prevent the onset of early 
islet autoimmunity. In accordance with our findings, observation of a protective role of CMV 
infection in the pathogenesis of another autoimmune disease, celiac disease, has been reported 
[13]. This finding was also recently confirmed in a large population-based analysis comparing the 
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prevalence of antibody-positivity to CMV and other herpes group viruses and positivity for celiac 
disease-associated transglutaminase type 2 antibody (TG2A) among children [14].  
CMV infection is known to have a strong immunomodulatory effect. For example, CMV infection 
increases the number of effector memory T cells, influencing the composition of the adaptive 
immune cell repertoire and has been shown to cause an age-dependent decline of the diversity of 
the T-cell pool. [15, 16]. According to our recent unpublished results analyzing samples from the 
DIPP cohort, perinatal CMV infection induces alterations in the CD8+ memory and CD8+ naïve T-
cell compartments, and to a lesser extent in the CD4+ T-cell compartments. These effects last at 
least until the age of 2 years (Öling V et al., unpublished observations), indicating a strong and 
long-lasting effect of perinatal CMV infections on the developing immune system. 
Perinatal infections and microbial exposure are known to strongly affect the balance of the 
immune system in early life and among these CMV infection seems to be one of the strongest 
factors influencing the dynamics of the immune system in children [17]. Even though our study has 
a limitation of lacking information on confounding factors that affect microbial exposure in the 
perinatal period, e.g. information on the route of delivery and breastfeeding, a recently published 
study with the same DIPP cohort observed no association between breastfeeding and the 
emergence of islet autoimmunity or type 1 diabetes. This supports our interpretation that CMV 
infection is the main environmental factor behind the results observed here [18]. 
Our observation of the decelerating effect of early CMV infection on the progression rate of islet 
autoimmunity later in childhood could be caused by the strong, potentially tolerogenic 
immunomodulatory effect of CMV infection on T cells. The finding is in accordance with the 
hygiene hypothesis, which suggests that microbial exposures in early childhood stimulate 
immunoregulatory mechanisms that control allergic and autoimmune reactions. However, the 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
exact immunological mechanisms behind this protective effect remain to be elucidated. Of note, 
we compared children with and without early CMV infection for the distribution of HLA genotypes 
associated with T1D but could not see any significant difference in the frequency of children 
positive for either DR3-DQ2, DR4-DQ8 or combination of both haplotypes between the groups 
(data not shown). 
In conclusion, our current findings demonstrate a protective effect of CMV infection during early 
life on the development of clinical T1D among subjects at genetic risk for T1D. The results support 
the significance of the hygiene hypothesis for the pathogenesis of T1D and highlight the 
importance of early childhood infections for the maturation of healthy immune responses.   
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Table 1. Characteristics of the study population. 
 
 
         
Variable   All children           
Total N = 1402 
CMV- CMV+ 
CMV status, N   1361 (97.1 %) 1040 (76.4 %) 321 (23.6 %) 
Missing data, N      41 (2.9 %)     
Mean age (y) at CMV IgG measurement 
(range) 
  1.46  (0.75-2.13) 1.45  (0.75-2.13) 1.48  (0.75-2.09) 
Male   59.6 % 61.1 % 57.9 % 
Number of islet autoantibodies found 
persistently positive during follow-up, N * 
        
          No autoantibodies   1016  (74.7%) 771  (74.1%) 245  (76.3%) 
          At least 1 aab     345  (25.3%) 269  (25.9%)   76  (23.7%) 
          At least 2 aab     280  (20.6%) 221  (21.3%)   59  (18.4%) 
          3 or more aab     172  (12.6%) 138  (13.3%)   34  (10.6%) 
Type 1 diabetes, N     228  (16.8%) 186  (17.9%)   42  (13.1%) 
* Islet autoantibodies; IAA, GADA, IA-2A         
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Table 2. Characteristics of progression to islet autoimmunity and clinical type 1 diabetes 
 
 
   
Variable   All aab+ children Non-progressor Progressor 
Mean age (y) at sampling (+/- SD)   1.47 (1.22-1.72)  1.50 (1.28-1.72)  1.46 (1.19-1.73) 
Mean age (y) at first double positive aab 
time (range) 
  3.28 (0.34-13.99) 4.72 (0.58-13.99) 2.48 (0.34-10.60) 
    All children           CMV- CMV+ 
Mean age (y) at first double positive aab 
time (range) 
  3.28 (0.34-13.99) 3.20 (0.34-13.99) 3.55 (0.50-12.58) 
Mean age (y) at onset of diabetes (range)   6.55 (0.82-14.88) 6.46 (0.82-14.56) 6.91 (1.03-14.88) 
Mean time (y) of progression to diabetes 
(range) 
  4.07 (0.0-12.24) 4.06 (0.0-11.78) 4.37 (0.2-12.24) 
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Figure 1. Progression to clinical type 1 diabetes among children with early cytomegalovirus infection (line) 
compared to children without the infection (dashed), p=0.035 log-rank test. Follow-up starting from birth. 
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Figure 2. Seroconversion for islet autoantibodies among the children with early cytomegalovirus infection 
(line) compared to children without the infection (dashed), p= 0.357. Follow-up starting from birth. 
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Figure 3. Progression to clinical type 1 diabetes after seroconversion to islet autoantibodies in children with 
CMV-specific IgG antibodies (line) compared to those without CMV antibodies (dashed), p=0.015. 
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